Bearish flow noted in Sarepta (SRPT) with 2,723 puts trading, or 1.9x expected. Most active are Jan-27 7.5 puts and Jan-27 50 calls, with total volume in those strikes near 2,400 contracts. The Put/Call Ratio is 1.75, while ATM IV is up over 2 points on the day. Earnings are expected on August 6th.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRPT:
- Solid Biosciences initiated with a Buy at Citi
- Sarepta treatment of limb girdle muscular dystrophy granted orphan status
- Oppenheimer biotech analysts hold an analyst/industry conference call
- Sell Rating for Sarepta Therapeutics Amid FDA Investigation and Valuation Concerns
- FDA investigating risk of acute liver failure with Sarepta’s Elevidys